Journal
ZEITSCHRIFT FUR GASTROENTEROLOGIE
Volume 54, Issue 12, Pages 1334-1342Publisher
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0042-120417
Keywords
hepatocellular carcinoma (HCC); tumor antigen; immunotherapy
Categories
Ask authors/readers for more resources
Immunotherapy is considered a new treatment option for many tumor entities, as decades of research into cancer immunotherapy have recently yielded promising results. Indeed, impressive clinical results of checkpoint blockade inhibitors in malignant melanoma and non-small cell lung cancer indicate the therapeutic potential of tumor-specific immune restoration. Over the years, different immunotherapeutic approaches have been evaluated for the treatment of hepatocellular carcinoma (HCC) with some respectable results. In this review article, we will summarize the key studies of the past 30 years and will elucidate in which direction the dynamic field of HCC immunotherapy is currently moving.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available